KLRK1 and neoplasm: Tumor cells can also release EVs containing MHC class 1 related chain ligand A (MICA) that is capable of binding to the NK cells receptor, NKG2D, leading to its downregulation and resulting in a marked reduction in NK cytotoxicity independent of NKG2D ligand expression by the target cell [67].